ANALGESIC EFFECTS INDUCED BY THE AGONIST OF CANNABINOID TYPE 2 (CB2) RECEPTORS, AM1241, IN A MURINE MODEL OF BONE CANCER PAIN

被引：0
|
作者：
Curto-Reyes, V. [1 ]
Llames, S.
Hidalgo, A. [1 ]
Menendez, L. [1 ]
Baamonde, A. [1 ]
机构：
[1] Univ Oviedo, Area Farmacol, Dept Med, Asturias, Spain
来源：
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2008年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：85 / 85
页数：1
相关论文
共 50 条
  • [1] Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain
    Curto-Reyes, V.
    Llames, S.
    Hidalgo, A.
    Menendez, L.
    Baamonde, A.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (03) : 561 - 573
  • [2] In vitro pharmacological characterization of AM1241:: a protean agonist at the cannabinoid CB2 receptor?
    Yao, B. B.
    Mukherjee, S.
    Fan, Y.
    Garrison, T. R.
    Daza, A. V.
    Grayson, G. K.
    Hooker, B. A.
    Dart, M. J.
    Sullivan, J. P.
    Meyer, M. D.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (02) : 145 - 154
  • [3] Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain:: Pain inhibition by receptors not present in the CNS
    Ibrahim, MM
    Deng, HF
    Zvonok, A
    Cockayne, DA
    Kwan, J
    Mata, HP
    Vanderah, TW
    Lai, J
    Porreca, F
    Makriyannis, A
    Malan, TP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) : 10529 - 10533
  • [4] CB2 Agonist (AM1241) Improving Effect on Ovalbumin-Induced Asthma in Rats
    Parlar, Ali
    Arslan, Seyfullah Oktay
    [J]. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (01): : 3 - 17
  • [5] The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats
    de Carvalho, Cristiane R.
    Hoeller, Alexandre A.
    Franco, Pedro L. C.
    Martini, Athos P. S.
    Soares, Flavia M. S.
    Lin, Katia
    Prediger, Rui D.
    Whalley, Benjamin J.
    Walz, Roger
    [J]. EPILEPSY RESEARCH, 2016, 127 : 160 - 167
  • [6] Effects of cannabinoid receptor 2 synthetic agonist, AM1241, on bleomycin induced pulmonary fibrosis
    Parlar, Ali
    Arslan, Seyfullah Oktay
    Yumrutas, Onder
    Elibol, Ebru
    Yalcin, Alper
    Uckardes, Fatih
    Aydin, Hasan
    Dogan, Muhammed Fatih
    Kayhan Kustepe, Elif
    Ozer, Mehmet Kaya
    [J]. BIOTECHNIC & HISTOCHEMISTRY, 2021, 96 (01) : 48 - 59
  • [7] Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242
    Mancini, I.
    Brusa, R.
    Quadrato, G.
    Foglia, C.
    Scandroglio, P.
    Silverman, L. S.
    Tulshian, D.
    Reggiani, A.
    Beltramo, M.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (01) : 382 - 391
  • [8] AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis
    Kim, Kathline
    Moore, Dan H.
    Makriyannis, Alexandros
    Abood, Mary E.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 542 (1-3) : 100 - 105
  • [9] The cannabinoid CB2 receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis
    Avraham, Hava Karsenty
    Jiang, Shuxian
    Fu, Yigong
    Rockenstein, Edward
    Makriyannis, Alexandros
    Zvonok, Alexander
    Masliah, Eliezer
    Avraham, Shalom
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (02) : 468 - 479
  • [10] Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers
    Bingham, B.
    Jones, P. G.
    Uveges, A. J.
    Kotnis, S.
    Lu, P.
    Smith, V. A.
    Sun, S-C
    Resnick, L.
    Chlenov, M.
    He, Y.
    Strassle, B. W.
    Cummons, T. A.
    Piesla, M. J.
    Harrison, J. E.
    Whiteside, G. T.
    Kennedy, J. D.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (07) : 1061 - 1070
12345